Cart
sales@molnova.com
WYC-210
CAS No. 2131803-93-3
WYC-210( —— )
Catalog No. M22099 CAS No. 2131803-93-3
WYC-210 is a retinoid compound,and with lower anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 430 | In Stock |
|
| 10MG | 620 | In Stock |
|
| 25MG | 972 | In Stock |
|
| 50MG | 1332 | In Stock |
|
| 100MG | 1764 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWYC-210
-
NoteResearch use only, not for human use.
-
Brief DescriptionWYC-210 is a retinoid compound,and with lower anticancer activity.
-
DescriptionWYC-210 is a retinoid compound,and with lower anticancer activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2131803-93-3
-
Formula Weight340.4
-
Molecular FormulaC18H16N2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1(C)CCS(=O)c2ccc(cc12)C#Cc1ncc(cn1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cao, Xin, et al. Preparation of the retinoid compound and their application as anticancer agents. WO2017152725A1.
molnova catalog
related products
-
ERAP1-IN-1
ERAP1-IN-1 is an endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitor. ERAP1-IN-1 competitively inhibits ERAP1 activity towards a nonamer peptide representative of physiological substrates.
-
Pronase E
Pronase E is a mixture of proteolytic enzymes that is obtained from Streptomyces griseus and could digest protein into individual amino acids.
-
FGI-106 tetrahydroch...
FGI-106 tetrahydrochloride is active against Ebola, Rift Valley and Dengue Fever viruses with EC50s of 100 nM, 800 nM and 400-900 nM, respectively.?
